Sage Journals: Discover world-class research

Abstract

Keywords

euglycemic diabetic ketoacidosis starvation ketosis bariatric surgery laparoscopic Roux-en-Y gastric bypass SGLT2 inhibitor

Get full access to this article

View all access options for this article.

References

Pareek

Schauer

PR.

Kaplan

et al. Metabolic surgery: weight loss, diabetes, and beyond. J Am Coll Cardiol. 2018;71(6):670-687.doi:10.1016/j.jacc.2017.12.014

http://www.ncbi.nlm.nih.gov/pubmed/29420964

Tentolouris

Vlachakis

Tzeravini

Eleftheriadou

Tentolouris

. Sglt2 inhibitors: a review of their antidiabetic and cardioprotective effects. Int J Environ Res Public Health. 2019;16(16):2965. doi:10.3390/ijerph16162965

31426529

Handelsman

Henry

RR.

Bloomgarden

et al. American association of clinical endocrinologists and American College of endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22(6):753-762.doi:10.4158/EP161292.PS

http://www.ncbi.nlm.nih.gov/pubmed/27082665

Pories

WJ.

Swanson

MS.

MacDonald

et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339-352.doi:10.1097/00000658-199509000-00011

http://www.ncbi.nlm.nih.gov/pubmed/7677463

Euglycemic Diabetic Ketoacidosis Associated With Use of SGLT2 Inhibitor After Laparoscopic Roux-en-Y Gastric Bypass

Abstract

Keywords

Get full access to this article

References